Investor profile
Chris Garabedian
Angel, Operator angel & CEO at Perceptive Advisors, Chairman and CEO at Xontogeny
An angel investor and operator angel based in Boston, Massachusetts, United States, Chris Garabedian has one known investment, Landos Biopharma.
Is Chris Garabedian a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- Autoimmune DiseasesBiotechClinical TrialsPharmaceuticalsTherapeutics
Contacts
Chris Garabedian portfolio company (1)
- Landos Biopharma
Affiliated funds' portfolios
CEO at Perceptive Advisors, whose known portfolio counts 10 companies
- Adlai Nortye
- Alto Neuroscience
- Imperative Care
- Solid Biosciences
- Sutro Biopharma
- MedinCell
- Talkiatry
- Xilio Therapeutics
- Diamyd Medical
- Kiora Pharmaceuticals
Chairman and CEO at Xontogeny, whose known portfolio counts 8 companies
- TORL BioTherapeutics
- Neurosterix
- PolyCore Therapeutics
- Delve Bio
- Nephraegis Therapeutics
- Peroxitech Therapeutics
- Shifa Biomedical
- Tellus Therapeutics
Investor Profile
The known portfolio sits in sector Healthcare, and focus areas Autoimmune Diseases, Biotech, Clinical Trials and Pharmaceuticals.
Chris Garabedian is listed for Pre-Seed and Seed rounds in the database.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Colleagues
Jayanth Batchu
Associate/EIR
Boston, United States
Gabriel Gutierrez
Vice President
New York, United States
Fred Callori
Partner
New York, United States
Sean Mansoory
Investor
New York, United States
Adam Stone
Chief Investment Officer
New York, United States
Takeru Furuya
Investor
Cambridge, United States
Gianna Hoffman Luca
Venture Partner
San Francisco, United States
Similar investors
Showing 20 of 100
Barbara Lubash
angel investor
Orange County, United States
David Wiersma
angel investor
Tucson, United States
Yury Kukushkin
angel investor
Boston, United States
Shaunak Parikh
angel investor
New York, United States
Chris Jackson
angel investor and operator angel
New York, United States
Philip Zaorski
angel investor
New York, United States
Peter Bojo
angel investor
San Francisco, United States
Adrian Parton Mbe
angel investor
Cambridge, United Kingdom
Aditya Puri
angel investor
Austin, United States
Richard Ulevitch
angel investor
San Diego, United States
Gyuri Karady
Angel Investor
Montreal, Canada
Vik Bajaj
angel investor and operator angel
United States
Vijay Palkar
angel investor
New York, United States
Mark Velleca
angel investor and operator angel
Washington, United States
Jannah Boudreaux
angel investor
Los Angeles, United States
Uri Kedem
angel investor and operator angel
San Francisco, United States
Matt Crawford
angel investor
Austin, United States
Morgane Decultieux
venture capital investor
Paris, France
Perry Karsen
angel investor
San Francisco, United States
Sanem Tatlıdil Özal
venture capital investor
Istanbul, Turkey
Frequently asked questions
Who is Chris Garabedian?
Chris Garabedian is an angel investor and operator angel based in Boston, Massachusetts, United States with one known investment on file, Landos Biopharma. The sections above list the sectors, stages and firms attached to that record.
What does Chris Garabedian invest in?
Listed sectors include Healthcare; listed focus areas include Autoimmune Diseases, Biotech, Clinical Trials and Pharmaceuticals. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Chris Garabedian invest at?
The database lists Chris Garabedian for Pre-Seed and Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Chris Garabedian listed at?
Chris Garabedian is listed as CEO at Perceptive Advisors. 7 other people in the database share a firm with Chris Garabedian.
How do I contact Chris Garabedian?
An email address, a phone number and a LinkedIn page are on file for Chris Garabedian. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal